TRACI WILKE: Open Payments
NPI 1679832489 · FORT COLLINS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$862 in 38 payments from 17 companies in 2025. Trend: 2023 $638 · 2024 $543 · 2025 $862
Food & beverage: $862
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $140 |
| GENZYME CORPORATION | 4 | $98 |
| Organon LLC | 6 | $96 |
| Janssen Biotech, Inc. | 3 | $63 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $61 |
| LEO Pharma Inc. | 2 | $56 |
| Galderma Laboratories, L.P. | 3 | $56 |
| REVANCE THERAPEUTICS, INC. | 1 | $50 |
| Lilly USA, LLC | 2 | $43 |
| Almirall LLC | 2 | $40 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, Winlevi, VTAMA, RINVOQ, DAXXIFY, TALTZ.
Industry payments across CO — which companies pay providers there.
